Nuvation Bio Inc.NUVBNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank14
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-311.24%
↑ 67% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-939.00%
Historical baseline
PeriodValueYoY Change
TTM-311.24%+95.7%
2024-7200.75%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-